Key result
Plasma exchange in patients with hypertriglyceridemia-induced acute pancreatitis was associated with higher mortality (25.0% vs 0%, P<0.01) and no difference in complications or recurrence rates.
Why the study?
Hypertriglyceridemia-induced acute pancreatitis causes higher morbidity and mortality than other etiologies, but the role of plasma exchange is not well established.
Does plasma exchange improve clinical outcomes in patients with hypertriglyceridemia-induced acute pancreatitis?
Cohort (n=41)
Does plasma exchange improve clinical outcomes in patients with hypertriglyceridemia-induced acute pancreatitis?
Absolute Event Rate: 25% vs 0%
p-value: p=<0.01
In a retrospective cohort, plasma exchange effectively reduced plasma triglyceride levels but did not decrease mortality or recurrences in patients with hypertriglyceridemia-induced acute pancreatitis.
BACKGROUND: Hypertriglyceridemia (HTG)-induced acute pancreatitis (AP) leads to higher morbidity and mortality compared with other etiologies. The role of plasma exchange (PE) in this context is still not well established. We aimed to assess the clinical outcomes of patients with HTG-induced AP who underwent PE and compare it with those who did not. PATIENTS AND METHODS: We retrospectively evaluated the data of patients who were admitted with HTG-induced AP between January 2013 and May 2018. The endpoint of the study was to assess the clinical outcomes, which included complication rates, mortality, and pancreatitis recurrence rate. RESULTS: Overall, 41 patients were included in the final analysis. Of these, 12 (29.2%) underwent PE. Patients undergoing PE had more severe pancreatitis on the basis of the Japanese Severity Score [10 (83.3%) vs. 14 (48.3%), P=0.03, respectively). Although mortality was higher in patients who underwent PE [three (25.0%) vs. zero, P<0.01, respectively], there was no difference in terms of complications and recurrence rates. Over a median 21 months of follow-up, 11 (26.8%) patients had recurrent AP. CONCLUSION: Although PE effectively reduced plasma triglyceride levels, there was no decrease in mortality or recurrences.
No takes yet. Share an insight, caveat, or question.
Keskin et al. (2019) conducted a cohort in Hypertriglyceridemia-induced acute pancreatitis (n=41). Plasma exchange vs. No plasma exchange was evaluated on Clinical outcomes including complication rates, mortality, and pancreatitis recurrence rate (p=<0.01). Plasma exchange in patients with hypertriglyceridemia-induced acute pancreatitis was associated with higher mortality (25.0% vs 0%, P<0.01) and no difference in complications or recurrence rates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: